First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
16.03
-0.34 (-2.08%)
At close: Jun 26, 2026, 4:00 PM EDT
16.03
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:34 PM EDT
TRAX Market Cap
TRAX has a market cap or net worth of $559.32 million as of June 26, 2026.
Market Cap
559.32M
Enterprise Value
272.87M
1-Year Change
n/a
Ranking
Category
Stock Price
$16.03
Market Cap Chart
Since April 6, 2026, TRAX's market cap has decreased from $660.23M to $559.32M, a decrease of -15.28%. That is a compound annual growth rate of -52.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 559.32M | -2.08% |
| Jun 25, 2026 | 571.19M | -1.92% |
| Jun 24, 2026 | 582.35M | -6.13% |
| Jun 23, 2026 | 620.39M | -2.95% |
| Jun 22, 2026 | 639.23M | 5.17% |
| Jun 18, 2026 | 607.83M | -4.13% |
| Jun 17, 2026 | 633.99M | 6.01% |
| Jun 16, 2026 | 598.06M | -4.14% |
| Jun 15, 2026 | 623.88M | 1.36% |
| Jun 12, 2026 | 615.50M | 3.58% |
| Jun 11, 2026 | 594.22M | 3.71% |
| Jun 10, 2026 | 572.93M | 2.82% |
| Jun 9, 2026 | 557.23M | 1.40% |
| Jun 8, 2026 | 549.56M | -5.12% |
| Jun 5, 2026 | 579.21M | -8.79% |
| Jun 4, 2026 | 635.04M | 18.80% |
| Jun 3, 2026 | 534.55M | -5.08% |
| Jun 2, 2026 | 563.16M | -10.78% |
| Jun 1, 2026 | 631.20M | 13.35% |
| May 29, 2026 | 556.88M | 0.88% |
| May 28, 2026 | 552.00M | -1.98% |
| May 27, 2026 | 563.16M | -5.37% |
| May 26, 2026 | 595.09M | -0.73% |
| May 22, 2026 | 599.45M | 2.51% |
| May 21, 2026 | 584.80M | 3.68% |
| May 20, 2026 | 564.04M | -2.97% |
| May 19, 2026 | 581.31M | -6.35% |
| May 18, 2026 | 620.74M | 5.27% |
| May 15, 2026 | 589.68M | -6.94% |
| May 14, 2026 | 633.65M | -1.06% |
| May 13, 2026 | 640.42M | 3.48% |
| May 12, 2026 | 618.88M | -5.06% |
| May 11, 2026 | 651.89M | -3.99% |
| May 8, 2026 | 678.99M | 9.65% |
| May 7, 2026 | 619.22M | -12.00% |
| May 6, 2026 | 703.66M | -4.44% |
| May 5, 2026 | 736.33M | 3.11% |
| May 4, 2026 | 714.09M | -8.18% |
| May 1, 2026 | 777.68M | -3.82% |
| Apr 30, 2026 | 808.61M | -1.57% |
| Apr 29, 2026 | 821.46M | 17.91% |
| Apr 28, 2026 | 696.71M | 10.77% |
| Apr 27, 2026 | 628.95M | -0.33% |
| Apr 24, 2026 | 631.04M | -4.42% |
| Apr 23, 2026 | 660.23M | 0.69% |
| Apr 22, 2026 | 655.71M | 11.00% |
| Apr 21, 2026 | 590.73M | -8.60% |
| Apr 20, 2026 | 646.33M | -17.37% |
| Apr 17, 2026 | 782.20M | -11.38% |
| Apr 16, 2026 | 882.62M | 3.46% |
| Apr 14, 2026 | 853.08M | 3.37% |
| Apr 13, 2026 | 825.28M | 1.06% |
| Apr 10, 2026 | 816.60M | 2.17% |
| Apr 9, 2026 | 799.22M | -4.96% |
| Apr 8, 2026 | 840.92M | 27.37% |
| Apr 7, 2026 | 660.23M | - |
| Apr 6, 2026 | 660.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 592.79M |
| Faeth Therapeutics | 589.56M |
| Monopar Therapeutics | 587.35M |
| MiMedx Group | 585.36M |
| Gyre Therapeutics | 574.73M |
| ProKidney | 552.77M |
| Altimmune | 548.42M |
| REGENXBIO | 541.79M |